Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
02/2012
02/23/2012WO2012024621A2 Synthetic nanocarrier vaccines comprising peptides obtained or derived from human influenza a virus hemagglutinin
02/23/2012WO2012024433A2 Compounds that inhibit tau phosphorylation
02/23/2012WO2012024284A1 Lipidated immune response modifier compound compositions, formulations, and methods
02/23/2012WO2012023995A1 Modification of recombinant adenovirus capsid protein with immunogenic plasmodium circumsporozoite protein epitopes
02/23/2012WO2012023810A2 Pharmaceutical composition for promoting angiogenesis, and method for screening for active substances for promoting angiogenesis
02/23/2012WO2012023622A1 Reagent for tumor testing and pharmaceutical composition for tumor prevention
02/23/2012WO2012023614A1 Monoclonal antibody having immunosuppressive activity or fragment to which antigen thereof is bonded
02/23/2012WO2012023580A1 Method for producing low immunogenic streptavidin having antibody bonded thereto
02/23/2012WO2012023044A1 Soluble needle arrays for delivery of influenza vaccines
02/23/2012WO2012023008A2 Polysaccharide conjugation with detoxified e. coli heat labile enterotoxin (lt) used as vaccine
02/23/2012WO2012022985A1 Combined use of fc gamma riib (cd32b) and cd20 - specific antibodies
02/23/2012WO2012022814A1 Antibodies for epidermal growth factor receptor 3 (her3)
02/23/2012WO2012022747A1 Combination therapy of an afucosylated cd20 antibody with an anti-vegf antibody
02/23/2012WO2012022724A1 Combination anti - cancer therapy
02/23/2012WO2012022677A2 Novel combination therapy for the treatment of cancer
02/23/2012WO2012022032A1 Endogenous antiviral complex-probiotic-preparation for prawn
02/23/2012WO2012021934A1 Humanized anti-interleukin 3 receptor alpha chain antibodies
02/23/2012WO2012003470A3 Antibody formulations
02/23/2012WO2012001179A3 Linear ige peptide epitopes of hazelnut allergen cor a 1 and celery antigen api 1
02/23/2012WO2011143461A9 Heat shock proteins as autoantigens
02/23/2012WO2011139738A9 Therapies using zanolimumab to enhance the immune response
02/23/2012WO2011130164A3 Unconjugated anti-tfr antibodies and compositions thereof for the treatment of cancer
02/23/2012WO2011126576A3 Genetic signatures in the envelope glycoprotein of hiv-1
02/23/2012WO2011116299A3 Myeloid derived suppressor cell inhibiting agents
02/23/2012WO2011112670A3 Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease
02/23/2012WO2011103465A3 Botulinum neurotoxin antigenic compositions and methods
02/23/2012WO2011088288A3 Hybridoma cell lines and monoclonal antibodies recognizing anthrose saccharide of bacillus anthracis
02/23/2012WO2003099989A3 Compositions and methods relating to breast specific genes and proteins
02/23/2012US20120046638 Method of inducing a CTL response
02/23/2012US20120046221 Albumin fusion proteins
02/23/2012US20120045774 Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy
02/23/2012US20120045755 Her-2 binding antagonists
02/23/2012US20120045517 TREATMENT OF CELIAC DISEASE WITH IgA
02/23/2012US20120045511 Thermosensitive hepatitis b vaccine
02/23/2012US20120045504 oral drug devices and drug formulations
02/23/2012US20120045503 Compositions And Methods For Wound Healing
02/23/2012US20120045501 Connexin enhances chemotherapy-included apoptosis in human cancer cells inhibiting tumor cell proliferation
02/23/2012US20120045487 Multiphasic microfibers for spatially guided cell growth
02/23/2012US20120045479 Dry Powder Formulations, Vaccines and Methods
02/23/2012US20120045477 Method for Treating Cancer with Toxoplasma Gondii Vaccine
02/23/2012US20120045476 Live attenuated mycoplasma strains
02/23/2012US20120045475 Live attenuated vaccines
02/23/2012US20120045474 Substrate peptide sequences for plague plasminogen activator and uses thereof
02/23/2012US20120045473 Biomolecule Surface Display and Uses Thereof
02/23/2012US20120045472 Biochemically Stabilized HIV-1 ENV Trimer Vaccine
02/23/2012US20120045471 Recombinant parainfluenza virus vaccine comprising heterologous antigens derived from respiratory syncytial virus
02/23/2012US20120045470 Imatinib immunoassay
02/23/2012US20120045469 Vaccine
02/23/2012US20120045468 Immunogenic Compositions and Uses Thereof
02/23/2012US20120045467 Influenza virus vaccine composition and methods of use
02/23/2012US20120045466 Identification of antigenic peptides from multiple myeloma cells
02/23/2012US20120045465 Cancer antigen helper peptide
02/23/2012US20120045464 Cryptosporidium parvum antigens, antibodies thereto and diagnostic and therapeutic compositions thereof
02/23/2012US20120045463 Methods and compositions comprising supramolecular constructs
02/23/2012US20120045462 Inflammation Inhibiting Compounds
02/23/2012US20120045461 Compositions and Methods for Inducing an Immune Response in a Mammal and Methods of Avoiding an Immune Response to Oligonucleotide Agents Such as Short Interfering RNAs
02/23/2012US20120045460 Methods and compositions for treatment of graft rejection and promotion of graft survival
02/23/2012US20120045459 Methods for Treating Autophagy-Related Disorders
02/23/2012US20120045458 Use of notch regulators for modulating the immune response by induction/suppression of interleukin-22
02/23/2012US20120045457 Nontypable haemophilus influenzae antigens
02/23/2012US20120045456 Stabilized anti-respiratory syncytial virus (rsv) antibody formulations
02/23/2012US20120045455 Phosphotetrahydropyran compounds for the treatment of wounds and fibrotic disorders
02/23/2012US20120045454 2,4-pyrimidinediamine compounds and their uses
02/23/2012US20120045453 Anti-IL-6 Antibodies, Compositions, Methods and Uses
02/23/2012US20120045452 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045451 Mnk KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM
02/23/2012US20120045450 Method for preventing and treating cancer metastasis and bone loss associated with cancer metastasis
02/23/2012US20120045449 Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease
02/23/2012US20120045448 Trp-p8 active compounds and therapeutic treatment methods
02/23/2012US20120045447 T cell costimulating polypeptides and uses thereof
02/23/2012US20120045446 Therapeutic agent for diseases in which neoplastic proliferation of plasma cells occurs
02/23/2012US20120045445 Method of treating viral diseases
02/23/2012US20120045444 Treatment for Neoplastic Diseases
02/23/2012US20120045443 Agonist anti-trk-c monoclonal antibodies
02/23/2012US20120045442 Human monoclonal antibodies to ctla-4
02/23/2012US20120045441 Methods of treating lung disease and other inflammatory diseases
02/23/2012US20120045440 Method of treating rheumatoid arthritis with an anti-il-6r antibody
02/23/2012US20120045439 Tumor markers and methods of use thereof
02/23/2012US20120045438 Engineered anti-il-13 antibodies, compositions, methods and uses
02/23/2012US20120045437 MONOCLONAL ANTIBODIES THAT INHIBIT THE Wnt SIGNALING PATHWAY AND METHODS OF PRODUCTION AND USE THEREOF
02/23/2012US20120045436 Humanized Anti-CD70 Binding Agents and Uses Thereof
02/23/2012US20120045435 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
02/23/2012US20120045434 Combination therapy
02/23/2012US20120045433 Combination therapy
02/23/2012US20120045432 B lymphocyte stimulator assays
02/23/2012US20120045431 Method of stabilizing and sterilizing peptides or proteins
02/23/2012US20120045430 Dendrimer-like modular delivery vector
02/23/2012US20120045429 Methods and Agent for Modulating the RNA Polymerase II-Histone Surface
02/23/2012US20120045413 Human papilloma virus peptide-specific T-cell response for treatment of warts
02/23/2012US20120045412 Cycloalkylidene and heterocycloalkylidene inhibitor compounds
02/23/2012US20120045394 Human and mouse targeting peptides identified by phage display
02/23/2012US20120045392 Pyro-glutamate a beta targeting agents
02/23/2012US20120045391 Formulations Targeting IGFBP7 for Diagnosis and Therapy of Cancer
02/23/2012US20120045390 Composition and Methods for the Diagnosis and Treatment of Tumor
02/23/2012US20120045389 Methods and reagents for efficient and targeted gene transfer to monocytes and macrophages
02/23/2012CA2844109A1 Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
02/23/2012CA2808965A1 Soluble needle arrays for delivery of influenza vaccines
02/23/2012CA2808744A1 Combined use of fc gamma riib (cd32b) and cd20 specific antibodies
02/23/2012CA2808626A1 Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
02/23/2012CA2808624A1 Lipidated immune response modifier compound compositions, formulations, and methods
1 ... 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 ... 1823